How CAR-T Cell Therapy Actually Works (2026)
How CAR-T cell therapy works in 2026: the chimeric antigen receptor, the manufacturing loop, why solid tumors resist, and the move toward in vivo CAR-T.
mRNA Beyond Vaccines: Programmable Therapeutics Explained
mRNA beyond vaccines — how programmable therapeutics work, lipid nanoparticle delivery, the manufacturing platform, and the real limits today.
Cell-Free Biomanufacturing: Engineering Protein Production Without Living Cells
How cell-free biomanufacturing systems produce proteins and enzymes without living organisms. TX-TL systems, lysate preparation, reaction engineering, and industrial scale-up challenges.